Han Edward Kyu-Ho, McGonigal Thomas
Abbott Laboratories, Global Pharmaceutical Research Division, Cancer Research, 100 Abbott Park Rd, Abbott Park, IL 60064, USA.
Anticancer Agents Med Chem. 2007 Nov;7(6):681-4. doi: 10.2174/187152007784111296.
The focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that localizes to the points of cell contact with the extracellular matrix, called focal adhesions. FAK is involved in several cellular processes including invasion, motility, proliferation and apoptosis. In in vivo animal studies, FAK has been shown to contribute to tumor development and malignancy. Furthermore, FAK expression was shown to be elevated in a number of human cancers. Increased FAK expression and activity are correlated with malignant phenotype and poor prognosis in patients. Taken together, these studies suggest that FAK is a potentially good target for drug discovery. In this review, FAK and its relationship to cancer, as well as approaches to therapeutic intervention of FAK will be discussed.
粘着斑激酶(FAK)是一种非受体酪氨酸激酶,定位于细胞与细胞外基质接触的部位,即粘着斑。FAK参与多种细胞过程,包括侵袭、迁移、增殖和凋亡。在体内动物研究中,FAK已被证明有助于肿瘤发展和恶性转化。此外,在许多人类癌症中,FAK表达升高。FAK表达和活性增加与患者的恶性表型和不良预后相关。综上所述,这些研究表明FAK是一个潜在的良好药物研发靶点。在本综述中,将讨论FAK及其与癌症的关系,以及针对FAK的治疗干预方法。